Transient absence of hepatic uptake on gallium-67 scintigraphy following fludarabine therapy.
Huynh
Thien
T
Department of Nuclear Medicine, Royal North Shore Hospital, St. Leonards NSW, Australia.
Mansberg
Robert
R
Hsiao
Edward
E
Coyle
Luke
L
Roach
Paul
P
D000970:Antineoplastic Agents / Q000008:administration & dosage; D002951:Citrates / Q000493:pharmacokinetics*; D005708:Gallium / Q000493:pharmacokinetics*; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell / Q000000981:diagnostic imaging* / Q000378:metabolism*; D008099:Liver / Q000000981:diagnostic imaging* / Q000187:drug effects / Q000378:metabolism*; D008297:Male; D008657:Metabolic Clearance Rate; D008875:Middle Aged; D011877:Radionuclide Imaging; D019275:Radiopharmaceuticals / Q000493:pharmacokinetics; D013154:Spleen / Q000000981:diagnostic imaging / Q000187:drug effects / Q000378:metabolism; D013997:Time Factors; D014740:Vidarabine / Q000008:administration & dosage* / Q000031:analogs & derivatives*
D000970:Antineoplastic Agents; D002951:Citrates; D019275:Radiopharmaceuticals; D005708:Gallium; D014740:Vidarabine; C103850:gallium citrate; C024352:fludarabine